Skip to Main Content
Contribute Try STAT+ Today

Alphabet’s life sciences arm Verily is in the midst of a shakeup of its leadership.

The company is promoting Stephen Gillett to serve as both president and chief operating officer, it announced Monday. Along with that move, according to an Insider report on Tuesday, CEO Andy Conrad will be focusing more on long-term strategy. Gillett will partner with Conrad, the company shared in a blog post, “to advance the organization as it scales and evolves into being a broader commercial company.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment